| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,792 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,045 |
| 424/277.1 |
Cancer cell or component thereof |
384 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
968 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6610306 |
OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof |
Aug. 26, 2003 |
| 6610307 |
Immunity against pasteurella haemolytica leukotoxin |
Aug. 26, 2003 |
| 6610308 |
Immunostimulant emulsion |
Aug. 26, 2003 |
| 6610310 |
Polyanionic polymers as adjuvants for mucosal immunization |
Aug. 26, 2003 |
| 6610517 |
Compartmentalization of recombinant polypeptides in host cells |
Aug. 26, 2003 |
| 6610661 |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
Aug. 26, 2003 |
| 6607724 |
Compositions and methods for inhibiting angiogenesis |
Aug. 19, 2003 |
| 6607725 |
Conjugate vaccine for nontypeable Haemophilus influenzae |
Aug. 19, 2003 |
| 6607730 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Aug. 19, 2003 |
| 6607731 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Aug. 19, 2003 |
| 6605276 |
Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
Aug. 12, 2003 |
| 6605280 |
Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18 |
Aug. 12, 2003 |
| 6605282 |
Multi-subtype FIV vaccines |
Aug. 12, 2003 |
| 6605286 |
Delivery of biologically active polypeptides |
Aug. 12, 2003 |
| 6605287 |
Vaccines for Chlamydia psittaci infections |
Aug. 12, 2003 |
| 6605699 |
Galectin-11 polypeptides |
Aug. 12, 2003 |
| 6602506 |
Delivery of proteins into eukaryotic cells with recombinant Yersinia |
Aug. 5, 2003 |
| 6602508 |
Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine |
Aug. 5, 2003 |
| 6602705 |
Expression of HIV polypeptides and production of virus-like particles |
Aug. 5, 2003 |
| 6602709 |
Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
Aug. 5, 2003 |
| 6599502 |
Intracellular delivery vehicles |
Jul. 29, 2003 |
| 6599508 |
Papilloma virus-like particles, fusion proteins as well as processes for their production |
Jul. 29, 2003 |
| 6599509 |
Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
Jul. 29, 2003 |
| 6599510 |
Abundant extracellular products and methods for their production and use |
Jul. 29, 2003 |
| 6599519 |
Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
Jul. 29, 2003 |
| 6596277 |
Methods of decreasing cell adhesion |
Jul. 22, 2003 |
| 6596278 |
Immunological response potentiation process |
Jul. 22, 2003 |
| 6596281 |
Mycobacterium tuberculosis specific proteins and genes, mixtures of antigens and uses thereof |
Jul. 22, 2003 |
| 6596282 |
Treatment of chronic viral infections with M. vaccae |
Jul. 22, 2003 |
| 6596283 |
Meningococcal polysaccharide conjugate vaccines |
Jul. 22, 2003 |
| 6596478 |
Method and composition to detect C-type retroviral infection |
Jul. 22, 2003 |
| 6596504 |
Treatment of prophylaxis of diseases caused by pilus-forming bacteria |
Jul. 22, 2003 |
| 6592869 |
Vaccine composition and method of using the same |
Jul. 15, 2003 |
| 6592872 |
Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
Jul. 15, 2003 |
| 6592875 |
Method for treatment of lyme disease |
Jul. 15, 2003 |
| 6592876 |
Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
Jul. 15, 2003 |
| 6589529 |
Rotavirus subunit vaccine |
Jul. 8, 2003 |
| 6590076 |
Compositions for the treatment and diagnosis of breast cancer and methods for their use |
Jul. 8, 2003 |
| 6590090 |
Fas ligand-like protein, its production and use |
Jul. 8, 2003 |
| 6585957 |
Medicinal aerosol formulation |
Jul. 1, 2003 |
| 6585976 |
Mycobacterium strain with modified ERP gene and vaccine composition containing same |
Jul. 1, 2003 |
| 6585977 |
Non-virulent Porphyromonas gingivalis mutant |
Jul. 1, 2003 |
| 6585979 |
HIV envelope polypeptides and immunogenic composition |
Jul. 1, 2003 |
| 6585980 |
Flagellin gene, FlaC of Campylobacter |
Jul. 1, 2003 |
| 6585982 |
Treatment of infertility |
Jul. 1, 2003 |
| 6582697 |
Enhancement of the cellular immune response |
Jun. 24, 2003 |
| 6582699 |
Combination vaccine for enhancing immunity against brucellosis |
Jun. 24, 2003 |
| 6582705 |
Acellular antibordetella vaccine |
Jun. 24, 2003 |
| 6582706 |
Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS |
Jun. 24, 2003 |
| 6582911 |
Candida albicans KRE9 and uses thereof |
Jun. 24, 2003 |
|
|
|
